Company: SNWV
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001628280-25-050280
Chunk: 37

Company: SANUWAVE Health, Inc.
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 37
---
5 and December 31, 2024$- $- Common stock, par value $0.001, 2,500,000,000 shares authorized; 8,576,164 and 8,543,686 issued and outstanding at September 30, 2025 and December 31, 2024, respectively9 9 Additional paid-in capital242,767 238,685 Accumulated deficit(245,717)(251,421)Accumulated other comprehensive loss10 10 Total Stockholders’ Deficit(2,931)(12,717)Total Liabilities and Stockholders’ Deficit$35,599 $30,119 

The accompanying notes to condensed consolidated financial statements are an integral part of these financial statements.

4

Table of Contents

SANUWAVE HEALTH, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(UNAUDITED)

(In thousands, except share data)

Three Months Ended September 30,Nine Months Ended September 30,2025202420252024Revenue$11,451 $9,360 $30,957 $22,308 Cost of Revenues2,526 2,293 6,690 5,799 Gross Margin8,925 7,067 24,267 16,509 Operating Expenses:General and administrative4,810 2,545 13,316 8,059 Selling and marketing2,081 2,202 5,286 4,468 Research and development345 161 747 519 Depreciation and amortization222 206 588 568 Total Operating Expenses7,458 5,114 19,937 13,614 Operating Income1,467 1,953 4,330 2,895 Other Income (Expense):Interest expense(1,722)(3,315)(5,448)(9,948)Interest expense, related party- (346)- (1,056)Gain (Loss) on extinguishment of debt(477)- (477)5,205 Change in fair value of derivative liabilities6,097 (18,849)2,186 (17,633)Loss on impairment of assets(196)- (196)- Other expense(14)(106)(42)(893)Other income (See Note